THC And Driving Impairment Duration

Researchers at Australia’s Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney have defined durations of impairment after THC dosing – but it’s not straightforward.

With more people discovering the benefits of medical cannabis, this raises the important issue of potential impairment while driving. In Australia, any detectable amount of  tetrahydrocannabinol (THC) in a driver’s bloodstream or saliva is enough to land the person in legal hot water; even if there is no impairment. With THC remaining detectable for up to weeks after ingestion, this effectively puts patients using legally prescribed medicines containing the compound under a driving ban.


Western Australia Hemp Trial Update

Western Australia’s Department of Primary Industries and Regional Development says crops associated with its latest round of industrial hemp trials are in the ground.

The trials, now in their second year, will examine the potential for growing hemp in the state for grain production. This year, the research has been expanded beyond the Manjimup Research Facility to include a site at Busselton in the southwest of the state and another site much further north at the department’s Kununurra Research Facility.


Medicinal cannabis to manage chronic pain? We don’t have evidence it works

woman with back pain

As a pain specialist, I often have patients asking me whether they should try medicinal cannabis. There’s a common perception it can be an effective way to manage chronic pain.

But two expert groups have recently recommended against medicinal cannabis for people suffering persistent non-cancer pain.


Australian docs advised not to prescribe medical cannabis for chronic pain

Australia’s leading pain advisory body has a recommendation for doctors in the country: Don’t use medicinal cannabis to treat chronic pain.

According to the Sydney Morning Herald, despite the approval of the 100,000th cannabinoid script in the country, the Faculty of Pain Medicine at the Australian and New Zealand College of Anaesthetists (ANZCA) is advising doctors to hold tight.


Medical Cannabis And Long-COVID

Australian medical cannabis company Bod Australia Limited (ASX:BDA) has entered into an agreement with Drug Science UK involving a trial of Bod’s MediCabilis product in managing symptoms associated with long-COVID.

“Long-COVID” is a phenomenon where symptoms continue for weeks or months beyond the initial illness. Far from being isolated cases, it appears long-COVID is quite common; but as with the initial illness the impacts vary patient to patient. Even asymptomatic people who had relatively mild cases are reportedly experiencing long COVID.

At the time of writing, there have been more than 122 million cases of COVID-19 globally. It’s estimated 10% of those testing positive will have symptoms for 12 weeks after diagnosis.


Tasmania To Improve Medical Cannabis Access

In his State of the State address on Tuesday, Tasmanian Premier Peter Gutwein announced his Government will be making improvements to Tasmania’s medical cannabis Controlled Access Scheme.

Introduced in 2017, the Scheme currently only allows specialists the ability to prescribe medical cannabis products to patients in circumstances where conventional treatments have failed. Accessing these medications in the state is a complicated process involving seven steps – and approval rates have been very low.

The situation has forced many Tasmanians to not engage with the system, give up on applying and/or to seek medical cannabis via illicit channels. This carries risks other than prosecution as the quality of the products they are accessing may be questionable.


Medical cannabis company expands

inside of a grow room

 Little Green Pharma has agreed to acquire two properties underlying its South West WA cultivation and manufacturing facilities as well as two adjacent properties.

IT'S been a big week for South West-based Little Green Pharma, with the medical cannabis company signing a binding agreement to acquire land for expansion and delivering its first shipment of medicinal cannabis oils into a French national medicinal cannabis trial.

LGP has agreed to acquire two properties underlying its South West cultivation and manufacturing facilities, as well as two adjacent properties, with a total land area of about 16,000 square metres.


Do Hemp Farms Stink?

A hemp farm in Australia is reportedly on the nose, with its odour causing problems for some local residents.

The ABC reports some residents living close to a trial hemp crop in  Red Cliffs, Victoria are reporting headaches resulting from the smell – but others say the smell doesn’t concern them.

iHemp Victoria is the officially recognised trade association for industrial hemp in state. The organisation’s president Darren Christie said he had never heard of these sorts of complaints and trial crops have been grown around Victoria for the last 15 years.


Growing cannabis at home: how COVID-19 has fueled a boom around the world

Back in the days when “skunk” was mainly associated with Pepé Le Pew and hydroponics was a way of improving cucumbers, most of the UK’s cannabis supply was imported from places such as Morocco and Lebanon. This changed in the past two or three decades in the UK and many other countries as organised criminal gangs set up growing operations closer to home.


CSIRO Granted Medical Cannabis Manufacturing Licence

cannabis bud

Australia’s national science agency has been granted a manufacturing licence to develop medicinal cannabis products by the Australian Office of Drug Control.

The Commonwealth Scientific and Industrial Research Organisation (CSIRO) says it will work to bridge the gap between cannabis cultivation and medicine manufacture, developing protocols and the first prototype products before transferring the technology to manufacturers.


Subscribe to RSS - Australia